Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 6/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1714938 | 1.00 | MAPT (0.40) | MAPTTSHREPHX2FAAHTRPV1 | |
| SCHEMBL1713806 | 0.91 | MAPT (0.41) | MAPTTSHREPHX2FAAHTRPV1 | |
| SCHEMBL1714604 | 0.89 | MAPT (0.40) | MAPTTSHREPHX2FAAHTRPV1 | |
| SCHEMBL4912351 | 0.86 | — | — | |
| SCHEMBL25996476 | 0.86 | ALDH1A1 (0.44) | MAPTTSHREPHX2ALDH1A1KMT2A | |
| SCHEMBL8204966 | 0.84 | TSHR (0.54) | MAPTTSHRFAAHTRPV1ALDH1A1 | |
| SCHEMBL19287165 | 0.84 | TSHR (0.54) | MAPTTSHRFAAHTRPV1ALDH1A1 | |
| SCHEMBL21436162 | 0.84 | TSHR (0.54) | MAPTTSHRFAAHTRPV1ALDH1A1 | |
| SCHEMBL2160625 | 0.84 | TSHR (0.54) | MAPTTSHRFAAHTRPV1ALDH1A1 | |
| SCHEMBL28016022 | 0.84 | TSHR (0.54) | MAPTTSHRFAAHTRPV1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10577471-B2 | Method for curing curable compositions | BASF SE (DE) | 2020-03-03 | — | — | US | disclosed |
| EP-3201261-B1 | METHOD FOR CURING CURABLE COMPOSITIONS | BASF SE (DE) | 2018-12-12 | — | — | EP | disclosed |
| US-20180148554-A9 | METHOD FOR CURING CURABLE COMPOSITIONS | BASF SE (DE) | 2018-05-31 | — | — | US | disclosed |
| US-9840635-B2 | Binding agent systems | CONSTRUCTION RESEARCH & TECHNOLOGY, GMBH (DE) | 2017-12-12 | — | — | US | disclosed |
| US-20170306118-A1 | METHOD FOR CURING CURABLE COMPOSITIONS | BASF SE (DE) | 2017-10-26 | — | — | US | disclosed |
| EP-3066161-B1 | COATINGS FOR USE AS ADHESIVE | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2017-07-05 | — | — | EP | disclosed |
| US-20160280954-A1 | NOVEL BINDING AGENT SYSTEMS | SIKA TECHNOLOGY AG (CH) | 2016-09-29 | — | — | US | disclosed |
| EP-1613638-B1 | METHOD FOR PRODUCING ACYLPHOSPHINE OXIDE SOLIDS | BASF SE (DE) | 2013-08-07 | — | — | EP | disclosed |
| EP-1476452-B1 | ACYL- AND BISACYLPHOSPHINE DERIVATIVES | BASF SE (DE) | 2011-07-20 | — | — | EP | disclosed |
| US-7776109-B2 | Method for producing acylphosphine oxide solids | BASF AKTIENGESELLSCHAFT (DE) | 2010-08-17 | — | — | US | disclosed |
| US-20070135556-A1 | Coating materials containing alpha-(1'-hydroxyalkyl)acrylates | BASF AKTIENGESELLSCHAFT (DE) | 2007-06-14 | — | — | US | disclosed |
| EP-1695146-A1 | COATING MATERIALS CONTAINING alpha-(1 -HYDROXYALKYL)ACRYLATES | BASF AKTIENGESELLSCHAFT (DE) | 2006-08-30 | — | — | EP | disclosed |
| EP-1546163-B1 | METHOD FOR THE PRODUCTION OF ACYLPHOSPHINE OXIDES | BASF AG (DE) | 2006-07-12 | — | — | EP | disclosed |
| US-20060052636-A1 | Method for the production of acylphosphine oxides | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-09 | — | — | US | disclosed |
| EP-1613638-A2 | METHOD FOR PRODUCING ACYLPHOSPHINE OXIDE SOLIDS | BASF AKTIENGESELLSCHAFT (DE) | 2006-01-11 | — | — | EP | disclosed |
| US-20050222294-A1 | Acyl- and bisacylphosphine derivatives | IGM GROUP B.V. (NL) | 2005-10-06 | — | — | US | disclosed |
| WO-2005057286-A1 | COATING MATERIALS CONTAINING α-(1'-HYDROXYALKYL)ACRYLATES | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-23 | — | — | WO | disclosed |
| WO-2004094439-A2 | METHOD FOR THE PRODUCTION OF ACYLPHOSPHINES | BASF AKTIENGESELLSCHAFT (DE) | 2004-11-04 | — | — | WO | disclosed |
| WO-2004087723-A2 | METHOD FOR PRODUCING ACYLPHOSPHINE OXIDE SOLIDS | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-14 | — | — | WO | disclosed |
| US-20040116702-A1 | Alkoxylated acyl-and bisacylphoshine derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2004-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060052636-A1 | Method for the production of acylphosphine oxides | AGPAT5, PNPO, PHOSPHO1 | MAPT 3413/4885TSHR 3990/4885EPHX2 1606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.